Previous 10 | Next 10 |
2023-06-08 10:04:22 ET Gainers: Aclarion ( ACON ) +35% . Bone Biologics ( BBLG ) +17% . Atara Biotherapeutics ( ATRA ) +16% . Medigus ( MDGS ) +15% . AVITA Medical ( RCEL ) +13% . Losers: Panbela Therapeutics ( PBLA ) ...
2023-05-30 08:34:33 ET Arlington Asset Investment ( AAIC ) +53% Announce Definitive Merger Agreement. Equitrans Midstream ( ETRN ) +33% . HeartBeam ( BEAT ) +28% Enters into Strategic Alliance Agreement with Samsung. Wearable Devices (...
2023-05-26 10:05:44 ET Gainers: Elevation Oncology ( ELEV ) +58% . Arcus Biosciences ( RCUS ) +26% . Healthcare Triangle ( HCTI ) +17% . PDS Biotechnology ( PDSB ) +16% . NEXGEL ( NXGL ) +12% . Losers: Tilray Brands (...
2023-05-26 08:34:32 ET Onfolio Holdings ( ONFO ) +62% Completes Development of Generative AI Search Tool. Elevation Oncology ( ELEV ) +58% . Quhuo Limited ( QH ) +37% Sector Exceeded RMB12 Million in Sales During the Labor Day Holiday, Achieving Impre...
LANGHORNE, Pa., May 24, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading provider of ultra-gentle, high-water-content hydrogel products for healthcare and consumer applications, today announced that A...
2023-05-15 16:27:29 ET NEXGEL press release ( NASDAQ: NXGL ): Q1 GAAP EPS of -$0.15 misses by $0.01 . Revenue of $0.6M (+53.8% Y/Y) beats by $0.15M . For further details see: NEXGEL GAAP EPS of -$0.15 misses by $0.01, revenue of $0.6M beats by $0.15M
202 3 first quarter revenue increased 56.6 % year-over-year to $ 620 thousand Approximately $5.8 million in cash and securities at March 31, 2023 Provide s second quarter 2023 revenue guidance of $ 1.0 mil...
Management will host a conference call at 4:30 P . M . ET on the same day LANGHORNE, Pa., May 09, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: “NXGL”), a leading p...
2023-03-28 13:10:56 ET Gainers: Biomea Fusion ( BMEA ) +73% . Oscar Health ( OSCR ) +72% . Viking Therapeutics ( VKTX ) +63% . Pyxis Oncology ( PYXS ) +46% . Bird Global ( BRDS ) +44% . NaaS Technology ( NAAS ) +26% ....
2022 revenue increased 32% YoY to $2.05 million, while gross profit margin improved As of December 31, 2022, had over $6.6 million in cash and securities which is sufficient to operate through 2025 LANGHORNE, Pa., March 27, 2023 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL...
News, Short Squeeze, Breakout and More Instantly...
LANGHORNE, Pa., July 08, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications,...
LANGHORNE, Pa., June 27, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications,...
LANGHORNE, Pa., June 11, 2024 (GLOBE NEWSWIRE) -- NEXGEL, Inc. (“NEXGEL” or the “Company”) (NASDAQ: NXGL), a leading provider of medical and over-the-counter (OTC) products including ultra-gentle, high-water-content hydrogels for healthcare and consumer applications,...